Fresenius Medical Care AG & Co. KGaA (FMS) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 5 Buy, 12 Hold, 1 Sell.
The consensus price target is $28.00, representing an upside of 20.6% from the current price $23.21.
Analysts estimate Earnings Per Share (EPS) of $1.45 and revenue of $19.36B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.92 vs est $1.45 (missed -36.4%). 2025: actual $1.68 vs est $1.94 (missed -13.3%). Analyst accuracy: 64%.
FMS Stock — 12-Month Price Forecast
$28.00
▲ +20.64% Upside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for Fresenius Medical Care AG & Co. KGaA, the price target is $28.00.
The average price target represents a +20.64% change from the last price of $23.21.
FMS Analyst Ratings
Hold
Based on 18 analysts giving stock ratings to Fresenius Medical Care AG & Co. KGaA in the past 3 months
EPS Estimates — FMS
64%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.92
vs Est $1.45
▼ 57.3% off
2025
Actual $1.68
vs Est $1.94
▼ 15.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — FMS
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $19.336B
vs Est $19.360B
▼ 0.1% off
2025
Actual $19.628B
vs Est $19.576B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
